Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAsan, Ziya
dc.contributor.authorEser, Mediha
dc.contributor.authorTanriverdi, Taner
dc.contributor.authorIsler, Cihan
dc.contributor.authorAlkan, Faruk
dc.contributor.authorErdincler, Pamir
dc.date.accessioned2019-11-26T20:14:10Z
dc.date.available2019-11-26T20:14:10Z
dc.date.issued2019
dc.identifier.issn2667-663X
dc.identifier.urihttps://dx.doi.org/10.4328/ACAM.5964
dc.identifier.urihttps://hdl.handle.net/20.500.12513/3815
dc.descriptionWOS: 000486455600009en_US
dc.description.abstractAim: The aim of this study is to compare the dosage-related effects of levetiracetam and valproic acid on neural tube defect formation in chick embryos, when applied as monotherapy and in combination. Material and Method: A total of 360 fertilized pathogens-free white-Leghorn eggs were used in the study. The eggs were allowed to incubate for 72 hours. Total of six groups were formed where each medication was administered in low (250 mcg) and high (500 mcg) doses and in combination. Results obtained from the control and sham groups were compared. Results: The prevalence of NTD was found to be significantly lower in the group that received levetiracetam compared to the group that was treated with valproic acid. It was determined that NTD prevalence increased with a dosage increase in both groups. The prevalence of NTD was found to be significantly higher in groups where the two medications were administered in combination compared to the groups that received a single medication. Discussion: Both levetiracetam and valproic acid have the potential to create NTD. Valproic acid has a higher potential of creating NTD compared to levetiracetam. The likeliness of causing NTD significantly increases depending on dosage for both medications. Both medications have the potential to create NTD during pregnancy and must be used with caution.en_US
dc.language.isoengen_US
dc.publisherBAYRAKOL MEDICAL PUBLISHERen_US
dc.relation.isversionof10.4328/ACAM.5964en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeural Tube Defecten_US
dc.subjectLevetiracetamen_US
dc.subjectValproic Aciden_US
dc.subjectTeratogenityen_US
dc.titleComparison of the effects of levetiracetam and valproic acid on neural tube defect formation in the chick embryo: an experimental studyen_US
dc.typearticleen_US
dc.relation.journalANNALS OF CLINICAL AND ANALYTICAL MEDICINEen_US
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri, Nöroloji ABDen_US
dc.identifier.volume10en_US
dc.identifier.issue4en_US
dc.identifier.startpage453en_US
dc.identifier.endpage457en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster